Search - tctmd.com

Displaying 81 - 100 of 432

Sort: Relevancy | Date

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Yael L. Maxwell

March 10, 2020

News Daily News

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

L.A. McKeown

March 09, 2020

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

L.A. McKeown

February 25, 2020

News Daily News

BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns

Michael O'Riordan

February 21, 2020

News Daily News

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Shelley Wood

February 14, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Todd Neale

January 15, 2020

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

Shelley Wood

January 14, 2020

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Daily News

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Michael O'Riordan

December 05, 2019

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

News Conference News TCT 2019

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

L.A. McKeown

October 04, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Caitlin E. Cox

September 10, 2019

Advertisement

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

The Cancer Patient Needing PCI Poses Conundrums for Care

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content